Menopause is associated with a range of symptoms which may affect quality of life as well may increase an individual’s risk of chronic conditions such as osteoporosis or cardiovascular disease.  […]

Research Competition The Osteoporosis Research Program provides training awards to support Canadian investigators conducting research that promises to yield new insights into the prevention and treatment of osteoporosis and improving […]

Community Backbone Award Form Recipients of the Community Backbone Award recognize individuals who volunteer in communities across the country who, through their actions, efforts and ideas, have made a significant […]

Osteoporosis Canada advises individuals on denosumab therapy to discuss their treatment with their physician prior to delaying therapy, stopping therapy or missing a scheduled dose.   Denosumab (Prolia) has been […]

FRACTURE RISK ASSESSMENT Determining your risk of breaking a bone Rather than relying solely on the results of a bone mineral density (BMD) test to make treatment decisions for osteoporosis, […]

Recommendations from Osteoporosis Canada Rapid Response Team We are aware of the recent study by Dr. Meryl Leboff that concluded vitamin D3 supplementation of 2000 IU daily does not significantly […]

Available Volunteer Opportunities Call for Nominations – Board of Directors After evaluating the strengths of the existing Board of Directors, the Board Development Committee is seeking individuals with the following […]

Osteoporosis Canada’s overall position statement in response to this study: This study did not specifically address the vitamin D requirements of individuals with osteoporosis, those with risk factors for osteoporotic […]

CAROC In 2005, Osteoporosis Canada, in association with the Canadian Association of Radiologists, launched the 10-year absolute fracture risk assessment – CAROC. In addition to BMD (lowest T-score of hip […]